CL2011000095A1 -
Use of a dosage form comprising a decongestant and a corticosteroid to prepare a useful medication to treat or relieve one or more symptoms of an allergic or inflammatory condition; dosage form.
- Google Patents
Use of a dosage form comprising a decongestant and a corticosteroid to prepare a useful medication to treat or relieve one or more symptoms of an allergic or inflammatory condition; dosage form.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=66221448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000095(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Sharp & DohmefiledCriticalMerck Sharp & Dohme
Publication of CL2011000095A1publicationCriticalpatent/CL2011000095A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Método de tratamiento con una composición farmacéutica que comprende un descongestionante y un corticosteroide, para el tratamiento de una condición alérgica o inflamatoria.Method of treatment with a pharmaceutical composition comprising a decongestant and a corticosteroid, for the treatment of an allergic or inflammatory condition.
CL2011000095A2008-07-152011-01-14
Use of a dosage form comprising a decongestant and a corticosteroid to prepare a useful medication to treat or relieve one or more symptoms of an allergic or inflammatory condition; dosage form.
CL2011000095A1
(en)
Use of a dosage form comprising a decongestant and a corticosteroid to prepare a useful medication to treat or relieve one or more symptoms of an allergic or inflammatory condition; dosage form.
Pharmaceutical composition comprising a) an activatable pharmaceutical agent, b) a plasmonic active agent; Useful for the treatment of cell proliferation disorders.
Compounds derived from substituted pyridazine; hedgehog and smo signaling inhibitors; pharmaceutical composition; and use for the treatment of disorders or syndromes associated with hyperproliferative diseases.
Pharmaceutical composition comprising micronized progesterone and type II safflower oil; and use for the treatment of a condition related to insufficient progesterone secretion.
COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE PI3 QUINASA ACTIVITY; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE FOR CANCER PROFILACTIC OR THERAPEUTIC TREATMENT.
Pharmaceutical composition comprising a therapeutically effective amount of one or more therapeutic agents and an amount improving the intestinal absorption of one or more zonulin / zot receptor agonists; and use of the composition to treat diabetes.
Use of a pharmaceutical composition comprising trns-clomineph to prepare a drug useful in the treatment of reduction of fasting glucose levels in a male.
Pharmaceutical composition comprising 0.5 to 50 mg of gaboxadol or a pharmaceutically acceptable salt thereof, and one or more inhibitors of pat1 and / or one or more inhibitors of oat, wherein said composition provides an in vivo plasma profile with a tmax longer than 20 minutes, useful in sleep disorders treatments.